BCL6B Antikörper (Middle Region)

Produktnummer ABIN927916

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch BCL6B in WB. Er zeigt eine Reaktivität gegenüber Human, Maus, Rind (Kuh), Ratte, Hund, Zebrafisch (Danio rerio), Huhn und Xenopus laevis.

Kurzübersicht für BCL6B Antikörper (Middle Region) (ABIN927916)

Target: BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))

Reaktivität: Human, Maus, Rind (Kuh), Ratte, Hund, Zebrafisch (Danio rerio), Huhn, Xenopus laevis

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BCL6B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-BCL6B Antikörper

Bindungsspezifität: Middle Region

Kreuzreaktivität: Maus, Ratte (Rattus), Rind (Kuh), Hund, Huhn, Frosch, Zebrafisch (Brachydanio rerio)

Aufreinigung: Purified

Immunogen: BCL6 B antibody was raised in rabbit using the middle region of BCL6 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

BCL6B Blocking Peptide, (ABIN5612306), is also available for use as a blocking control in assays to test for specificity of this BCL6B antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu BCL6B

Target: BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))

Andere Bezeichnung: BCL6B

Hintergrund: BCL6B acts as a sequence-specific transcriptional repressor in association with BCL6. BCL6B may function in a narrow stage or be related to some events in the early B-cell development. Synonyms: Polyclonal BCL6B antibody, Anti-BCL6B antibody, B-cell CLL/lymphoma 6, member B, zinc finger protein antibody, BAZF antibody, ZBTB28 antibody, ZNF62 antibody.

Pathways: BCR Signaling